1-Alkyl-2,3-dihydro-4(1H)-quinolinones by a tandem Michael-SNAr annulation reaction

Journal of Heterocyclic Chemistry

Volumn 46, Issue 4, 2009, Pages 623-628

  Bunce, Richard A ^a   Nago, Takahiro ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AROMATIC AMINE; N,N DIMETHYLFORMAMIDE; QUINOLINE DERIVATIVE;

ANNULATION REACTION; ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; MICHAEL ADDITION; SYNTHESIS;

EID: 67749145561     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.70     Document Type: Article

References (31)

1. (a) Bunce, R. A.; Rogers, D.; Nago, T.; Bryant, S. A. J Heterocyclic Chem 2008, 45, 547;
2. (b) Bunce, R. A.; Nago, T.; Sonobe, N.; Slaughter, L. M. J Heterocyclic Chem 2008, 45, 551;
3. (c) Bunce, R. A.; Nago, T. J Heterocyclic Chem 2008, 45, 1155.
4. See for example (a) Johnson, W. S.; Woroch, E. L.; Buell, B. G. J Am Chem Soc 1949, 71, 1901;
5. (b) Hurd, C. D.; Hayao, S. J Am Chem Soc 1954, 76, 5065;
6. (c) Allison, J. A. C.; Braunholtz, J. T.; Mann, F. G. J Chem Soc 1954, 403.
7. (a) Kano, S.; Ebata, T.; Shibuya, S. J Chem Soc Perkin Trans 1, 1980, 2105;
8. (b) Anderson, K. W.; Tepe, J. J. Tetrahedron 2002, 58, 8475.
9. Donnelly, J. A.; Farrell, D. F. J Org Chem 1990, 55, 1757.
10. Baraznenok, I. L.; Nenaidenko, V. G.; Balenkova, E. S. Chem Heterocyclic Compd 1997, 33, 429.
11. (a) Bayburt, E. K.; Daanen, J. F.; Gomtsyan, A. R.; Latshaw, S. P.; Lee, C.-H.; Schmidt, R. G. U.S. Pat. 20080153871 (2008), 45;
12. (b) Bayburt, E. K.; Daanen, J. F.; Gomtsyan, A. R.; Latshaw, S. P.; Lee, C.-H.; Schmidt, R. G. Chem Abstr 2008, 149, 104611;
13. (c) Glamkowski, E. J.; Hamer, R. R. L. U.S. Pat. 4,786,644 (1988), 14;
14. (d) Glamkowski, E. J.; Hamer, R. R. L. Chem Abstr 1989, 110, 135097.
15. Bagolini, C.; de Witt, P.; Pacifici, L.; Ramacci, M. T. J Med Chem 1978, 21, 476.
16. (a) Hom, R.; Tucker, J.; Varghese, J.; Shah, N. World Patent WO 2005095326 (2005), 365;
17. (b) Hom, R.; Tucker, J.; Varghese, J.; Shah, N. Chem Abstr 2005, 143, 386930.
18. (c) Varghese, J.; Maillard, M.; Fang, L; Tucker, J.; Brogley, L.; Aquino, J.; Bowers, S.; Probst, G.; Tung, J. World Patent WO 2005087714 (1995), 428;
19. (d) VargheseJ.; Maillard, M.; Fang, L; Tucker, J.; Brogley, L.; Aquino, J.; Bowers, S.; Probst, G.; Tung, J. Chem Abstr 2005, 143, 326226.
20. These compounds are also currently being evaluated for the treatment of: (a) Central nervous system disorders: Galley, G.; Groebke Zbinden, K. G.; Norcross, R.; Stalder, H. World Patent WO 2007085558 (2007), 85;
21. (b) Galley, G.; Groebke Zbinden, K. G.; Norcross, R.; Stalder, H. Chem Abstr 2007, 147, 841292;
22. (c) Potassium channel blockers: Gerlach, U.; Brendel, J.; Lang, H. J.; Weidmann, K. Eur. Pat. EP 857,724 (1998), 23;
23. (d) Gerlach, U.; Brendel, J.; Lang, H. J.; Weidmann, K. Chem Abstr 1998, 129, 175447.
24. (e) Cancer: Vicker, N.; Day, J. M.; Bailey, H. V.; Heaton, W.; Gonzalez, A. M. R.; Sharland, C. M.; Reed, M. J.; Purohit, A.; Potter, B. V. L. World Patent 2007003934 (2007), 266;
25. (f) Vicker, N.; Day, J. M.; Bailey, H. V.; Heaton, W.; Gonzalez, A. M. R.; Sharland, C. M.; Reed, M. J.; Purohit, A.; Potter, B. V. L. Chem Abstr 2007, 146, 142281.
26. Gale, D. J.; Wilshire, J. F. K. Aust J Chem 1970, 23, 1063.
27. Shen, W.; Coburn, C. A.; Bornmann, W. G.; Danishefsky, S. J. J Org Chem 1993, 58, 611.
28. 13C nmr spectra were obtained using ACD HNMR and CNMR software from Advanced Chemistry Development, Inc. Toronto, Canada, 2007.
29. Still, W. C.; Kahn, M.; Mitra, A. J Org Chem 1978, 43, 2923.
30. Eisenbraun, E. J. Organic Syntheses; Wiley: New York, NY, 1973; Vol. V, pp 310-314.
31. This is a known compound, but it is reported with only a boiling point (175-177°C, 0.2 mmHg), see Atwal, M. S.; Bauer, L.; Dixit, S. N.; Gearien, J. E.; Morris, R. W. J Med Chem 1965, 8, 566. Reference 8a also reports this compound without a melting point.